233 related articles for article (PubMed ID: 23183121)
1. Prediction of concentration levels of metformin and other high consumption pharmaceuticals in wastewater and regional surface water based on sales data.
Oosterhuis M; Sacher F; Ter Laak TL
Sci Total Environ; 2013 Jan; 442():380-8. PubMed ID: 23183121
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical concentration variability at sewage treatment plant outlets dominated by hydrology and other factors.
Brunsch AF; Ter Laak TL; Rijnaarts H; Christoffels E
Environ Pollut; 2018 Apr; 235():615-624. PubMed ID: 29331894
[TBL] [Abstract][Full Text] [Related]
3. Different compositions of pharmaceuticals in Dutch and Belgian rivers explained by consumption patterns and treatment efficiency.
ter Laak TL; Kooij PJ; Tolkamp H; Hofman J
Environ Sci Pollut Res Int; 2014 Nov; 21(22):12843-55. PubMed ID: 24972658
[TBL] [Abstract][Full Text] [Related]
4. Comparison of measured and predicted concentrations of selected pharmaceuticals in wastewater and surface water: a case study of a catchment area in the Po Valley (Italy).
Verlicchi P; Al Aukidy M; Jelic A; Petrović M; Barceló D
Sci Total Environ; 2014 Feb; 470-471():844-54. PubMed ID: 24200722
[TBL] [Abstract][Full Text] [Related]
5. Occurrence and removal of frequently prescribed pharmaceuticals and corresponding metabolites in wastewater of a sewage treatment plant.
Gurke R; Rößler M; Marx C; Diamond S; Schubert S; Oertel R; Fauler J
Sci Total Environ; 2015 Nov; 532():762-70. PubMed ID: 26124013
[TBL] [Abstract][Full Text] [Related]
6. Consumption-based approach for assessing the contribution of hospitals towards the load of pharmaceutical residues in municipal wastewater.
Le Corre KS; Ort C; Kateley D; Allen B; Escher BI; Keller J
Environ Int; 2012 Sep; 45():99-111. PubMed ID: 22580296
[TBL] [Abstract][Full Text] [Related]
7. Total Release of 21 Indicator Pharmaceuticals Listed by the Swedish Medical Products Agency from Wastewater Treatment Plants to Surface Water Bodies in the 1.3 Million Populated County Skåne (Scania), Sweden.
Björklund E; Svahn O
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011310
[TBL] [Abstract][Full Text] [Related]
8. Measured and predicted environmental concentrations of carbamazepine, diclofenac, and metoprolol in small and medium rivers in northern Germany.
Meyer W; Reich M; Beier S; Behrendt J; Gulyas H; Otterpohl R
Environ Monit Assess; 2016 Aug; 188(8):487. PubMed ID: 27465046
[TBL] [Abstract][Full Text] [Related]
9. Occurrence and fate of the antidiabetic drug metformin and its metabolite guanylurea in the environment and during drinking water treatment.
Scheurer M; Michel A; Brauch HJ; Ruck W; Sacher F
Water Res; 2012 Oct; 46(15):4790-802. PubMed ID: 22770965
[TBL] [Abstract][Full Text] [Related]
10. Concentrations of prioritized pharmaceuticals in effluents from 50 large wastewater treatment plants in the US and implications for risk estimation.
Kostich MS; Batt AL; Lazorchak JM
Environ Pollut; 2014 Jan; 184():354-9. PubMed ID: 24095705
[TBL] [Abstract][Full Text] [Related]
11. Spatial distribution of pharmaceuticals in conventional wastewater treatment plant with Sludge Treatment Reed Beds technology.
Kołecka K; Gajewska M; Stepnowski P; Caban M
Sci Total Environ; 2019 Jan; 647():149-157. PubMed ID: 30077845
[TBL] [Abstract][Full Text] [Related]
12. Occurrence and suitability of pharmaceuticals and personal care products as molecular markers for raw wastewater contamination in surface water and groundwater.
Tran NH; Li J; Hu J; Ong SL
Environ Sci Pollut Res Int; 2014 Mar; 21(6):4727-40. PubMed ID: 24352549
[TBL] [Abstract][Full Text] [Related]
13. Development of predicted environmental concentrations to prioritize the occurrence of pharmaceuticals in rivers from Catalonia.
Gómez-Canela C; Pueyo V; Barata C; Lacorte S; Marcé RM
Sci Total Environ; 2019 May; 666():57-67. PubMed ID: 30784823
[TBL] [Abstract][Full Text] [Related]
14. Pharmaceuticals and consumer products in four wastewater treatment plants in urban and suburb areas of Shanghai.
Sui Q; Wang D; Zhao W; Huang J; Yu G; Cao X; Qiu Z; Lu S
Environ Sci Pollut Res Int; 2015 Apr; 22(8):6086-94. PubMed ID: 25391230
[TBL] [Abstract][Full Text] [Related]
15. Widespread occurrence and seasonal variation of pharmaceuticals in surface waters and municipal wastewater treatment plants in central Finland.
Lindholm-Lehto PC; Ahkola HS; Knuutinen JS; Herve SH
Environ Sci Pollut Res Int; 2016 Apr; 23(8):7985-97. PubMed ID: 26769590
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of Pharmaceuticals in Calgary's Wastewater and Related Surface Water.
Chen M; Cooper VI; Deng J; Amatya PL; Ambrus D; Dong S; Stalker N; Nadeau-Bonilla C; Patel J
Water Environ Res; 2015 May; 87(5):414-24. PubMed ID: 26460461
[TBL] [Abstract][Full Text] [Related]
17. Occurrence and seasonal variations of 25 pharmaceutical residues in wastewater and drinking water treatment plants.
Kot-Wasik A; Jakimska A; Śliwka-Kaszyńska M
Environ Monit Assess; 2016 Dec; 188(12):661. PubMed ID: 27837362
[TBL] [Abstract][Full Text] [Related]
18. The presence of the top prescribed pharmaceuticals in treated sewage effluents and receiving waters in Southwest Nova Scotia, Canada.
Ghoshdastidar AJ; Fox S; Tong AZ
Environ Sci Pollut Res Int; 2015 Jan; 22(1):689-700. PubMed ID: 25099660
[TBL] [Abstract][Full Text] [Related]
19. Behavior of sartans (antihypertensive drugs) in wastewater treatment plants, their occurrence and risk for the aquatic environment.
Bayer A; Asner R; Schüssler W; Kopf W; Weiß K; Sengl M; Letzel M
Environ Sci Pollut Res Int; 2014 Sep; 21(18):10830-9. PubMed ID: 24898294
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceuticals released from senior residences: occurrence and risk evaluation.
Lacorte S; Luis S; Gómez-Canela C; Sala-Comorera T; Courtier A; Roig B; Oliveira-Brett AM; Joannis-Cassan C; Aragonés JI; Poggio L; Noguer T; Lima L; Barata C; Calas-Blanchard C
Environ Sci Pollut Res Int; 2018 Mar; 25(7):6095-6106. PubMed ID: 28748440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
